| Net Cash Provided by (Used in) Operating Activities |
$144,042,000 |
USD |
-61% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$226,352,000 |
USD |
25% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
499,950,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
139,486,706 |
shares |
47% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$82,310,000 |
USD |
-11% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$122,927,000 |
USD |
-6.2% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$18,799,000 |
USD |
-31% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$2,880,632,000 |
USD |
47% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$92,898,000 |
USD |
81% |
Q1 2024 |
Q1 2024 |